US Bancorp’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.85M Sell
19,735
-2,180
-10% -$452K ﹤0.01% 694
2026
Q1
$4.92M Sell
21,915
-1,290
-6% -$321K 0.01% 597
2025
Q4
$5.59M Sell
23,205
-326
-1% -$83.4K 0.01% 575
2025
Q3
$6.44M Sell
23,531
-53
-0.2% -$14.5K 0.01% 537
2025
Q2
$6.08M Sell
23,584
-6,060
-20% -$1.45M 0.01% 549
2025
Q1
$6.64M Sell
29,644
-1,930
-6% -$451K 0.01% 508
2024
Q4
$7.22M Buy
31,574
+1,254
+4% +$302K 0.01% 491
2024
Q3
$7.4M Sell
30,320
-54
-0.2% -$12.1K 0.01% 496
2024
Q2
$5.81M Sell
30,374
-2,129
-7% -$432K 0.01% 539
2024
Q1
$6.44M Sell
32,503
-1,360
-4% -$249K 0.01% 520
2023
Q4
$5.83M Buy
33,863
+1,669
+5% +$256K 0.01% 539
2023
Q3
$4.76M Sell
32,194
-1,168
-4% -$211K 0.01% 553
2023
Q2
$7.29M Sell
33,362
-4,105
-11% -$915K 0.01% 476
2023
Q1
$8.2M Sell
37,467
-2,556
-6% -$555K 0.01% 443
2022
Q4
$8.33M Sell
40,023
-2,302
-5% -$506K 0.01% 442
2022
Q3
$9.24M Sell
42,325
-1,793
-4% -$408K 0.02% 375
2022
Q2
$9.25M Buy
44,118
+2,705
+7% +$576K 0.02% 388
2022
Q1
$10M Buy
41,413
+515
+1% +$125K 0.02% 409
2021
Q4
$10.7M Buy
40,898
+506
+1% +$131K 0.02% 409
2021
Q3
$10.6M Buy
40,392
+1,338
+3% +$366K 0.02% 388
2021
Q2
$9.63M Sell
39,054
-218
-0.6% -$45.8K 0.02% 414
2021
Q1
$7.62M Sell
39,272
-5,083
-11% -$1.02M 0.02% 460
2020
Q4
$9.43M Sell
44,355
-611
-1% -$122K 0.02% 387
2020
Q3
$7.71M Sell
44,966
-503
-1% -$92.9K 0.02% 403
2020
Q2
$8.73M Buy
45,469
+455
+1% +$74.4K 0.02% 377
2020
Q1
$6.63M Buy
45,014
+1,057
+2% +$168K 0.02% 388
2019
Q4
$6.81M Sell
43,957
-416
-0.9% -$60K 0.02% 430
2019
Q3
$5.99M Sell
44,373
-158
-0.4% -$20.7K 0.02% 462
2019
Q2
$5.43M Sell
44,531
-167
-0.4% -$18.5K 0.02% 493
2019
Q1
$4.65M Buy
44,698
+1,720
+4% +$178K 0.01% 514
2018
Q4
$4.89M Sell
42,978
-4,278
-9% -$458K 0.02% 470
2018
Q3
$5.45M Sell
47,256
-1,186
-2% -$130K 0.02% 482
2018
Q2
$5.02M Sell
48,442
-4,621
-9% -$468K 0.02% 497
2018
Q1
$5.23M Sell
53,063
-3,986
-7% -$377K 0.02% 495
2017
Q4
$4.83M Buy
57,049
+76
+0.1% +$6.28K 0.01% 516
2017
Q3
$4.38M Buy
56,973
+966
+2% +$73.9K 0.01% 523
2017
Q2
$4.36M Sell
56,007
-1,114
-2% -$79.7K 0.01% 526
2017
Q1
$4.11M Buy
57,121
+1,100
+2% +$76K 0.01% 535
2016
Q4
$3.48M Buy
56,021
+5,558
+11% +$340K 0.01% 568
2016
Q3
$3.27M Buy
50,463
+2,743
+6% +$183K 0.01% 565
2016
Q2
$3.02M Buy
47,720
+9,900
+26% +$584K 0.01% 579
2016
Q1
$2.19M Buy
37,820
+24,451
+183% +$1.38M 0.01% 670
2015
Q4
$718K Sell
13,369
-14,207
-52% -$801K ﹤0.01% 1136
2015
Q3
$1.41M Buy
27,576
+171
+0.6% +$9.2K 0.01% 809
2015
Q2
$1.54M Sell
27,405
-241
-0.9% -$15.2K 0.01% 815
2015
Q1
$1.99M Sell
27,646
-149
-0.5% -$9.68K 0.01% 721
2014
Q4
$1.56M Buy
27,795
+571
+2% +$29.8K 0.01% 800
2014
Q3
$1.34M Buy
27,224
+73
+0.3% +$3.72K 0.01% 851
2014
Q2
$1.38M Buy
27,151
+2,075
+8% +$103K 0.01% 849
2014
Q1
$1.12M Sell
25,076
-461
-2% -$20.7K ﹤0.01% 910
2013
Q4
$1.2M Buy
25,537
+21,831
+589% +$1.11M ﹤0.01% 846
2013
Q3
$196K Sell
3,706
-28
-0.7% -$1.36K ﹤0.01% 1698
2013
Q2
$169K Buy
+3,734
New +$177K ﹤0.01% 1732

Other funds holding RMD

US Bancorp's RMD Position: Q2 2026 in Review

US Bancorp reduced its ResMed (RMD) stake by 9.9% in Q2 2026, selling an estimated $452K and leaving 19,735 shares worth $3.85M. The position accounts for ﹤0.01% of the portfolio, ranked #694.

US Bancorp first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.7M in Q4 2021. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • US Bancorp held 19,735 shares of ResMed worth $3.85M as of Q2 2026.
  • US Bancorp sold 2,180 ResMed shares in Q2 2026, an estimated $452K.
  • ResMed made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #694 holding.
  • US Bancorp first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • US Bancorp's ResMed position peaked at $10.7M in Q4 2021.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.